New heart valve shows promise in early trial for aortic stenosis
NCT ID NCT05712161
First seen Apr 09, 2026 · Last updated May 24, 2026 · Updated 6 times
Summary
This early study tests a new device called DurAVR™ THV to replace a narrowed heart valve in people with severe aortic stenosis. The goal is to see if the procedure is safe and feasible in 15 patients aged 65 or older. The device is delivered through a leg artery, avoiding open-heart surgery.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AORTIC STENOSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Cleveland Clinic Foundation
Cleveland, Ohio, 44195, United States
-
Columbia University Medical Center/NYPH
New York, New York, 10032, United States
-
Montefiore Medical Center
The Bronx, New York, 10467, United States
-
Tucson Medical Center
Tucson, Arizona, 85712, United States
-
University of Michigan
Ann Arbor, Michigan, 48109, United States
Conditions
Explore the condition pages connected to this study.